BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21870073)

  • 1. A synthetic decursin analog with increased in vivo stability suppresses androgen receptor signaling in vitro and in vivo.
    Zhang Y; Shaik AA; Xing C; Chai Y; Li L; Zhang J; Zhang W; Kim SH; Lü J; Jiang C
    Invest New Drugs; 2012 Oct; 30(5):1820-9. PubMed ID: 21870073
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel class of pyranocoumarin anti-androgen receptor signaling compounds.
    Guo J; Jiang C; Wang Z; Lee HJ; Hu H; Malewicz B; Lee HJ; Lee JH; Baek NI; Jeong JH; Kim DK; Kang KS; Kim SH; Lu J
    Mol Cancer Ther; 2007 Mar; 6(3):907-17. PubMed ID: 17363485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potent antiandrogen and androgen receptor activities of an Angelica gigas-containing herbal formulation: identification of decursin as a novel and active compound with implications for prevention and treatment of prostate cancer.
    Jiang C; Lee HJ; Li GX; Guo J; Malewicz B; Zhao Y; Lee EO; Lee HJ; Lee JH; Kim MS; Kim SH; Lu J
    Cancer Res; 2006 Jan; 66(1):453-63. PubMed ID: 16397261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oriental herbs as a source of novel anti-androgen and prostate cancer chemopreventive agents.
    Lu J; Kim SH; Jiang C; Lee H; Guo J
    Acta Pharmacol Sin; 2007 Sep; 28(9):1365-72. PubMed ID: 17723170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tanshinones from Chinese medicinal herb Danshen (Salvia miltiorrhiza Bunge) suppress prostate cancer growth and androgen receptor signaling.
    Zhang Y; Won SH; Jiang C; Lee HJ; Jeong SJ; Lee EO; Zhang J; Ye M; Kim SH; Lü J
    Pharm Res; 2012 Jun; 29(6):1595-608. PubMed ID: 22281759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models.
    Wu W; Tang SN; Zhang Y; Puppala M; Cooper TK; Xing C; Jiang C; Lü J
    Am J Chin Med; 2017; 45(8):1773-1792. PubMed ID: 29121805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-(3,4-Dihydro-1H-isoquinoline-2-yl)-N-(6-methoxypyridine-2-yl) nicotinamide-26 (DIMN-26) decreases cell proliferation by induction of apoptosis and downregulation of androgen receptor signaling in human prostate cancer cells.
    Choi HE; Shin JS; Leem DG; Kim SD; Cho WJ; Lee KT
    Chem Biol Interact; 2016 Dec; 260():196-207. PubMed ID: 27720946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decursin and decursinol angelate inhibit estrogen-stimulated and estrogen-independent growth and survival of breast cancer cells.
    Jiang C; Guo J; Wang Z; Xiao B; Lee HJ; Lee EO; Kim SH; Lu J
    Breast Cancer Res; 2007; 9(6):R77. PubMed ID: 17986353
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galbanic acid decreases androgen receptor abundance and signaling and induces G1 arrest in prostate cancer cells.
    Zhang Y; Kim KH; Zhang W; Guo Y; Kim SH; Lü J
    Int J Cancer; 2012 Jan; 130(1):200-12. PubMed ID: 21328348
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-androgen receptor signaling and prostate cancer inhibitory effects of sucrose- and benzophenone-compounds.
    Wang Z; Lee HJ; Wang L; Jiang C; Baek NI; Kim SH; Lü J
    Pharm Res; 2009 May; 26(5):1140-8. PubMed ID: 19266268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White button mushroom (Agaricus bisporus) disrupts androgen receptor signaling in human prostate cancer cells and patient-derived xenograft.
    Wang X; Ha D; Mori H; Chen S
    J Nutr Biochem; 2021 Mar; 89():108580. PubMed ID: 33388344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel anticancer agent, decursin, induces G1 arrest and apoptosis in human prostate carcinoma cells.
    Yim D; Singh RP; Agarwal C; Lee S; Chi H; Agarwal R
    Cancer Res; 2005 Feb; 65(3):1035-44. PubMed ID: 15705905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models.
    Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX
    J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative determination of decursin, decursinol angelate, and decursinol in mouse plasma and tumor tissue using liquid-liquid extraction and HPLC.
    Li L; Zhang J; Shaik AA; Zhang Y; Wang L; Xing C; Kim SH; Lü J
    Planta Med; 2012 Feb; 78(3):252-9. PubMed ID: 22116603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity.
    Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y
    Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decursin and Decursinol Angelate Suppress Adipogenesis through Activation of β-catenin Signaling Pathway in Human Visceral Adipose-Derived Stem Cells.
    Park IS; Kim B; Han Y; Yang H; Cho U; Kim SI; Kim JH; Yoon Park JH; Lee KW; Song YS
    Nutrients; 2019 Dec; 12(1):. PubMed ID: 31861646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lgr4 promotes prostate tumorigenesis through the Jmjd2a/AR signaling pathway.
    Zhang J; Li Q; Zhang S; Xu Q; Wang T
    Exp Cell Res; 2016 Nov; 349(1):77-84. PubMed ID: 27743893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Zyflamend inhibits the expression and function of androgen receptor and acts synergistically with bicalutimide to inhibit prostate cancer cell growth.
    Yan J; Xie B; Capodice JL; Katz AE
    Prostate; 2012 Feb; 72(3):244-52. PubMed ID: 21656835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. D,L-Sulforaphane causes transcriptional repression of androgen receptor in human prostate cancer cells.
    Kim SH; Singh SV
    Mol Cancer Ther; 2009 Jul; 8(7):1946-54. PubMed ID: 19584240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.